IP Library Granted Patent US 12,077,638
Granted Patent B2
US 12,077,638 · App. 15/335,184 · Granted Sep 3, 2024

Methods of generating microparticles and porous hydrogels using microfluidics

Inventors: John Oakey (Laramie, WY); Kaspars Krutkramelis (Laramie, WY); Bingzhao Xia (Calamvale, AU)
Assignee: University of Wyoming
C08J3/075A61K9/5026A61K35/12A61L27/16A61L27/18A61L27/38A61L27/52A61L27/56B01F23/41B01F25/4331B01F33/3011B01J2/06B01J13/0052B01J19/0093C08F2/32C08F2/48C08J9/26C12N5/0012B01J2219/00792B01J2219/00936C08F216/125C08F222/102C08J2201/046C08J2205/022C08J2207/10C08J2335/02C08J2345/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,077,638
App. No.
15/335,184
Granted
Sep 3, 2024
Kind
B2
Abstract

Provided herein are methods utilizing microfluidics for the oxygen-controlled generation of microparticles and hydrogels having controlled microparticle sizes and size distributions and products from provided methods. The included methods provide the generation of microparticles by polymerizing an aqueous solution dispersed in a non-aqueous continuous phase in an oxygen-controlled environment. The process allows for control of size of the size of the aqueous droplets and, thus, control of the size of the generated microparticles which may be used in biological applications.

Claims (40)

1. A method of preparing a plurality of microparticles in a microfluidics device in an oxygen-controlled environment comprising the steps of:

(a) providing a continuous phase comprising a non-aqueous liquid and an aqueous phase comprising a polyethylene glycol (PEG)-based photodegradable macromer having a molecular weight selected from the range of 200 to 20,000 Daltons, a biological material, and an initiator;

(b) forming a composition comprising microdroplets of said aqueous phase dispersed in said non-aqueous liquid;

(c) controlling oxygen concentration in the microdroplets to enhance viability of the biological material, wherein the controlling comprises:

(i) providing said composition comprising said microdroplets and said non-aqueous liquid in a first channel of said microfluidics device;

(ii) flowing said oxygen-free gas through a second channel, adjacent to said first channel;

(iii) diffusing at least some of said oxygen-free gas into a region of the microfluidics device between the first and second channels; and

(iv) varying a supply pressure of the oxygen-free gas in order to vary the oxygen concentration within the microdroplets; and

(d) partially polymerizing said monomer or said macromer in said microdroplets, wherein, as polymerization is impeded by dissolved oxygen, only a fraction of a radial volume of each microdroplet is polymerized and the rest remains as a liquid film of un-polymerized aqueous phase on a polymerized core thereby generating microparticles within said aqueous phase having a smaller radius than said microdroplets; wherein the partially polymerizing step is at least partially controlled via the controlling oxygen concentration step (c); and wherein the microparticles have a mean diameter of less than or equal to 1000 μm.

2. The method of claim 1 , wherein said oxygen-free gas is nitrogen.

3. The method of claim 1 , wherein said oxygen-free gas is varied within the range of 0.1 atm to 10 atm.

4. The method of claim 1 , where said initiator is a photoinitiator and said step of polymerizing said monomer or macromer is carried out in the presence of ultraviolet light.

5. The method of claim 4 , wherein said photoinitiator is lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP) or Irgacure 1173.

6. The method of claim 1 , wherein said non-aqueous liquid comprises a fluorocarbon oil.

7. The method of claim 6 , wherein said fluorocarbon oil is a segregated hydrofluoroether.

8. The method of claim 1 , wherein said non-aqueous liquid further comprises a surfactant and said surfactant is provided at a concentration selected from the range of 0.1% to 4%.

9. The method of claim 8 , wherein said surfactant is a Dolomite FluoroPEG surfactant, RAN Biotechnologies FluoroPEG surfactant or Krytox FSL 157.

10. The method of claim 1 , wherein said microparticles are hydrogel microparticles.

11. The method of claim 1 , wherein said microparticles are photodegradable.

12. The method of claim 1 , wherein said macromer is a PEG-diacrylate (PEGDA) macromer.

13. The method of claim 1 , wherein said step (c) of controlling oxygen concentration in the microdroplets reduces the amount of oxygen in the composition to a preselected concentration selected from the range of 1% to 90%.

14. The method of claim 1 , wherein said step(c) of controlling oxygen concentration in the microdroplets reduces the amount of oxygen in the non-aqueous liquid to a preselected concentration selected from the range of 1% to 90%.

15. The method of claim 1 , wherein said step (c) of controlling oxygen concentration in the microdroplets comprises providing a membrane between said composition and said oxygen-free gas.

16. The method of claim 15 , wherein said membrane is a polydimethylsiloxane membrane.

17. The method of claim 1 , further comprising the steps of:

(e) at least partially encapsulating said microparticles within a non-photodegradable polymer, wherein said microparticles are photodegradable; and

(f) photodegrading said photodegradable microparticles to produce a composite porous hydrogel.

18. The method of claim 1 , wherein said biological material comprises cells.

19. The method of claim 18 , wherein said pores of said composite porous hydrogel have a lateral dimension to receive an individual cell.

20. The method of claim 1 wherein said biological material is selected from the group consisting of: mesenchymal stem cells, ß cells, satellite muscle cells, proteins, therapeutic small molecules, imaging molecules, secondary nanoparticles and any combination thereof.

21. The method of claim 1 , wherein said composition is a water in oil emulsion.

22. The method of claim 1 , wherein said microparticles are photodegradable microparticles and further comprising:

(e) at least partially encapsulating said photodegradable microparticles within a non-photodegradable polymer;

(f) photodegrading said photodegradable microparticles to produce a composite porous hydrogel; and

(g) contacting said composite porous hydrogel with a biological material, thereby capturing a portion of said biologically material in said composite porous hydrogel.

23. The method of claim 1 , wherein the step of regulating oxygen exposure (c)(iv) comprises varying a residence time of the microdroplets in the first channel of said microfluidics device.

24. The method of claim 18 , comprising tuning viability of the cells via the step of controlling oxygen concentration in the microdroplets.

25. The method of claim 1 comprising removing the un-polymerized liquid film from the microparticles.

26. The method of claim 1 comprising removing the non-aqueous phase from the microparticles to induce self-assembly of a hexagonal matrix of microparticles surrounded by un-polymerized aqueous phase.

27. The method of claim 26 comprising polymerizing the un-polymerized aqueous phase of the hexagonal matrix to form an ordered structure.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2017
From: OAKEY, JOHN; KRUTKRAMELIS, KASPARS; XIA, BINGZHAO
To: UNIVERSITY OF WYOMING
Reel/Frame 042577/0637 →
Continuity (2)
Provisional Application 62285352 · Oct 26, 2015
Related Publication 20170145169A1 · May 25, 2017